Recently, Nanjing Lanbo Aix Biotechnology Co., Ltd. has successfully obtained a record certificate for pathogenic microorganism laboratories related to human health, thanks to its comprehensive biosafety management system and intelligent laboratory facilities. This filing strictly complies with the requirements of the "Regulations on Biosafety Management of Pathogenic Microbial Laboratories", covering core materials such as laboratory legal person qualifications, biosafety organizational structure, floor plan layout, and emergency plans.

As an innovative enterprise in the field of biotechnology, Lambert Aix adopts IoT intelligent control system in laboratory construction to achieve precise monitoring of air circulation, waste treatment and other links, and verifies equipment stability through technologies such as organoid culture and stem cell preparation. The R&D team holds a biosafety training certificate and regularly conducts leak emergency drills. This marks the compliance of Lambex in the field of pathogenic microorganism research, laying a safe foundation for the subsequent development and clinical technology application of stem cell drug CDMO.